The role of natriuretic peptides has been established for the evaluation of chronic RV dysfunction in pulmonary hypertension, where a diagnostic algorithm integrating symptoms, carbon monoxide diffusion capacity and NT-proBNP identified subjects at very low probability of pulmonary hypertension, who may be deferred from further evaluation [58]. Here, NPPB is linked to pulmonary arterial hypertension.